WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008092905) SPECIFIC ACTIVATION OF A REGULATORY T CELL AND ITS USE FOR TREATMENT OF ASTHMA, ALLERGIC DISEASE, AUTOIMMUNE DISEASE, GRAFT REJECTION AND FOR TOLERANCE INDUCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/092905    International Application No.:    PCT/EP2008/051144
Publication Date: 07.08.2008 International Filing Date: 30.01.2008
IPC:
G01N 33/50 (2006.01)
Applicants: BOEHRINGER INGELHEIM INTERNATIONAL GMBH [DE/DE]; Binger Str. 173, 55216 Ingelheim Am Rhein (DE) (For All Designated States Except US).
SCHNEIDER, Franz-Josef [DE/DE]; (DE) (For US Only).
BECKER, Christian [DE/DE]; (DE) (For US Only).
BOPP, Tobias [DE/DE]; (DE) (For US Only).
JONULEIT, Helmut [DE/DE]; (DE) (For US Only).
SCHMITT, Edgar [DE/DE]; (DE) (For US Only)
Inventors: SCHNEIDER, Franz-Josef; (DE).
BECKER, Christian; (DE).
BOPP, Tobias; (DE).
JONULEIT, Helmut; (DE).
SCHMITT, Edgar; (DE)
Agent: HAMMANN, Heinz; c/o Boehringer Ingelheim GmbH, Binger Str. 173, 55216 Ingelheim Am Rhein (DE)
Priority Data:
07101604.2 01.02.2007 EP
07122424.0 05.12.2007 EP
Title (EN) SPECIFIC ACTIVATION OF A REGULATORY T CELL AND ITS USE FOR TREATMENT OF ASTHMA, ALLERGIC DISEASE, AUTOIMMUNE DISEASE, GRAFT REJECTION AND FOR TOLERANCE INDUCTION
(FR) ACTIVATION SPÉCIFIQUE D'UN LYMPHOCYTE T RÉGULATEUR ET SON UTILISATION POUR LE TRAITEMENT DE L'ASTHME, D'UNE MALADIE ALLERGIQUE, D'UNE MALADIE AUTO-IMMUNE, D'UN REJET DE GREFFE ET POUR UNE INDUCTION DE TOLÉRANCE
Abstract: front page image
(EN)The present invention relates specific activation of a regulatory T cell via a specific CD4 epitope and uses thereof, e.g. for the treatment of an autoimmune disease or an allergy or asthma or graft rejection or tolerance induction.
(FR)La présente invention porte sur l'activation spécifique d'un lymphocyte T régulateur par l'intermédiaire d'un épitope CD4 spécifique et sur ses utilisations, par exemple pour le traitement d'une maladie auto-immune ou d'une allergie ou de l'asthme ou du rejet de greffe ou d'une induction de tolérance.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)